CEL.L
Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-03-31
Stock Exchange
LSE
Ticker
CEL.L
According to Celadon Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current PE Ratio is -1.67. This represents a change of -64.72% compared to the average of -4.73 of the last 4 quarters.
The mean historical PE Ratio of Celadon Pharmaceuticals Plc over the last ten years is -15.40. The current -1.67 PE Ratio has changed 984.66% with respect to the historical average. Over the past ten years (40 quarters), CEL.L's PE Ratio was at its highest in in the June 2019 quarter at 0. The PE Ratio was at its lowest in in the June 2021 quarter at -7.30.
Average
-15.40
Median
-9.97
Minimum
-44.66
Maximum
-1.66
Discovering the peaks and valleys of Celadon Pharmaceuticals Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 499.88%
Maximum Annual PE Ratio = -1.66
Minimum Annual Increase = -87.52%
Minimum Annual PE Ratio = -44.66
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -9.97 | 499.88% |
| 2022 | -1.66 | -87.52% |
| 2021 | -13.32 | 80.55% |
| 2020 | -7.37 | -83.49% |
The current PE Ratio of Celadon Pharmaceuticals Plc (CEL.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.32
5-year avg
-15.40
10-year avg
-15.40
Celadon Pharmaceuticals Plc’s PE Ratio is less than MGC Pharmaceuticals Limited (-0.06), greater than Induction Healthcare Group PLC (-2.78), less than Advanced Oncotherapy plc (-0.19), greater than BiVictriX Therapeutics Plc (-2.85), less than Argent BioPharma Limited (-0.25), less than Synairgen plc (-0.23), less than Cambridge Nutritional Sciences plc (2.96), greater than NetScientific plc (-6.45), less than Hellenic Dynamics Plc (-0.27), less than Theracryf Plc (-0.69),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.06 | N/A | |
| -2.78 | N/A | |
| -0.19 | N/A | |
| -2.85 | N/A | |
| -0.25 | N/A | |
| -0.23 | N/A | |
| 2.96 | N/A | |
| -6.45 | N/A | |
| -0.27 | N/A | |
| -0.69 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celadon Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celadon Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Celadon Pharmaceuticals Plc's PE Ratio?
How is the PE Ratio calculated for Celadon Pharmaceuticals Plc (CEL.L)?
What is the highest PE Ratio for Celadon Pharmaceuticals Plc (CEL.L)?
What is the 3-year average PE Ratio for Celadon Pharmaceuticals Plc (CEL.L)?
What is the 5-year average PE Ratio for Celadon Pharmaceuticals Plc (CEL.L)?
How does the current PE Ratio for Celadon Pharmaceuticals Plc (CEL.L) compare to its historical average?